Loading…
Purification of a cystic fibrosis plasmid vector for gene therapy using hydrophobic interaction chromatography
The success and validity of gene therapy and DNA vaccination in in vivo experiments and human clinical trials depend on the ability to produce large amounts of plasmid DNA according to defined specifications. A new method is described for the purification of a cystic fibrosis plasmid vector (pCF1‐CF...
Saved in:
Published in: | Biotechnology and bioengineering 2000-06, Vol.68 (5), p.576-583 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c4873-d719dd96e4a0ce251e83a62fc895d2f0ac6869ca6c2d9ca6438c0c5e741c0f873 |
container_end_page | 583 |
container_issue | 5 |
container_start_page | 576 |
container_title | Biotechnology and bioengineering |
container_volume | 68 |
creator | Diogo, M. M. Queiroz, J. A. Monteiro, G. A. Martins, S. A. M. Ferreira, G. N. M. Prazeres, D. M. F. |
description | The success and validity of gene therapy and DNA vaccination in in vivo experiments and human clinical trials depend on the ability to produce large amounts of plasmid DNA according to defined specifications. A new method is described for the purification of a cystic fibrosis plasmid vector (pCF1‐CFTR) of clinical grade, which includes an ammonium sulfate precipitation followed by hydrophobic interaction chromatography (HIC) using a Sepharose gel derivatized with 1,4‐butanediol‐diglycidylether. The use of HIC took advantage of the more hydrophobic character of single‐stranded nucleic acid impurities as compared with double‐stranded plasmid DNA. RNA, denatured genomic and plasmid DNAs, with large stretches of single strands, and lipopolysaccharides (LPS) that are more hydrophobic than supercoiled plasmid, were retained and separated from nonbinding plasmid DNA in a 14‐cm HIC column. Anion‐exchange HPLC analysis proved that >70% of the loaded plasmid was recovered after HIC. RNA and denatured plasmid in the final plasmid preparation were undetectable by agarose electrophoresis. Other impurities, such as host genomic DNA and LPS, were reduced to residual values with the HIC column ( |
doi_str_mv | 10.1002/(SICI)1097-0290(20000605)68:5<576::AID-BIT13>3.0.CO;2-5 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71086625</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17665226</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4873-d719dd96e4a0ce251e83a62fc895d2f0ac6869ca6c2d9ca6438c0c5e741c0f873</originalsourceid><addsrcrecordid>eNqFke9r1DAYx4so7jb9F6SvZHvRM0mbpD1F2TqdhemJnsx3D7k0vWb215JW7X9vus4hKFwghCTf5_OEfDzvDUZLjBB5cfwlS7MTjBIeIJKgY4LcYIiesHhFX1HOVqvT7Dw4yzY4fB0u0TJdvyQBfeAt7mseeoupJghpQg68Q2uv3ZbHjD32DjDiCScRXXjNp8HoQkvR67bx28IXvhxtr6Vf6K1prbZ-Vwlb69z_oWTfGr9wc6ca5felMqIb_cHqZueXY27army3rlQ3vbuSt0hZmrYWfbtz2XJ84j0qRGXV07v1yPv67u0mfR9cri-y9PQykFHMwyDnOMnzhKlIIKkIxSoOBSOFjBOakwIJyWKWSMEkyaclCmOJJFU8whIVjnDkPZ-5nWlvBmV7qLWVqqpEo9rBAsfI_QShe4MER1FMSLQ3iDljlBDmgldzULrvs0YV0BldCzMCRjDJBZjkwiQKJlHwRy6wGCg4uQBOLtzKhRAQpGsgML312d0Thm2t8r-4s00X-DYHfupKjf_03dv2f13nA4cOZrS2vfp1jxbmOzAecgpXHy_g7DM536APDh3-Bnzv0G4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17665226</pqid></control><display><type>article</type><title>Purification of a cystic fibrosis plasmid vector for gene therapy using hydrophobic interaction chromatography</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Diogo, M. M. ; Queiroz, J. A. ; Monteiro, G. A. ; Martins, S. A. M. ; Ferreira, G. N. M. ; Prazeres, D. M. F.</creator><creatorcontrib>Diogo, M. M. ; Queiroz, J. A. ; Monteiro, G. A. ; Martins, S. A. M. ; Ferreira, G. N. M. ; Prazeres, D. M. F.</creatorcontrib><description>The success and validity of gene therapy and DNA vaccination in in vivo experiments and human clinical trials depend on the ability to produce large amounts of plasmid DNA according to defined specifications. A new method is described for the purification of a cystic fibrosis plasmid vector (pCF1‐CFTR) of clinical grade, which includes an ammonium sulfate precipitation followed by hydrophobic interaction chromatography (HIC) using a Sepharose gel derivatized with 1,4‐butanediol‐diglycidylether. The use of HIC took advantage of the more hydrophobic character of single‐stranded nucleic acid impurities as compared with double‐stranded plasmid DNA. RNA, denatured genomic and plasmid DNAs, with large stretches of single strands, and lipopolysaccharides (LPS) that are more hydrophobic than supercoiled plasmid, were retained and separated from nonbinding plasmid DNA in a 14‐cm HIC column. Anion‐exchange HPLC analysis proved that >70% of the loaded plasmid was recovered after HIC. RNA and denatured plasmid in the final plasmid preparation were undetectable by agarose electrophoresis. Other impurities, such as host genomic DNA and LPS, were reduced to residual values with the HIC column (<6 ng/μg pDNA and 0.048 EU/μg pDNA, respectively). The total reduction in LPS load in the combined ammonium acetate precipitation and HIC was 400,000‐fold. Host proteins were not detected in the final preparation by bicinchoninic acid (BCA) assay and sodium dodecylsulfate‐polyacrylamide gel electrophoresis (SDS‐PAGE) with silver staining. Plasmid identity was confirmed by restriction analysis and biological activity by transformation experiments. The process presented constitutes an advance over existing methodologies, is scaleable, and meets quality standards because it does not require the use of additives that usually pose a challenge to validation and raise regulatory concerns. © 2000 John Wiley & Sons, Inc. Biotechnol Bioeng 68: 576–583, 2000.</description><identifier>ISSN: 0006-3592</identifier><identifier>EISSN: 1097-0290</identifier><identifier>DOI: 10.1002/(SICI)1097-0290(20000605)68:5<576::AID-BIT13>3.0.CO;2-5</identifier><identifier>PMID: 10797245</identifier><language>eng</language><publisher>New York: John Wiley & Sons, Inc</publisher><subject>Ammonium compounds ; Chromatography - methods ; Chromatography, High Pressure Liquid ; cystic fibrosis ; Cystic Fibrosis Transmembrane Conductance Regulator - genetics ; Cystic Fibrosis Transmembrane Conductance Regulator - isolation & purification ; DNA ; Endotoxins - analysis ; Escherichia coli - chemistry ; Escherichia coli - genetics ; gene therapy ; Genetic Therapy - methods ; Genetic Vectors - isolation & purification ; Humans ; Hydrophobic chromatography ; hydrophobic interaction chromatography ; nucleic acids ; plasmid purification ; Plasmids - genetics ; Precipitation (chemical) ; Purification ; Quality Control ; RNA</subject><ispartof>Biotechnology and bioengineering, 2000-06, Vol.68 (5), p.576-583</ispartof><rights>Copyright © 2000 John Wiley & Sons, Inc.</rights><rights>Copyright 2000 John Wiley & Sons, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4873-d719dd96e4a0ce251e83a62fc895d2f0ac6869ca6c2d9ca6438c0c5e741c0f873</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10797245$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Diogo, M. M.</creatorcontrib><creatorcontrib>Queiroz, J. A.</creatorcontrib><creatorcontrib>Monteiro, G. A.</creatorcontrib><creatorcontrib>Martins, S. A. M.</creatorcontrib><creatorcontrib>Ferreira, G. N. M.</creatorcontrib><creatorcontrib>Prazeres, D. M. F.</creatorcontrib><title>Purification of a cystic fibrosis plasmid vector for gene therapy using hydrophobic interaction chromatography</title><title>Biotechnology and bioengineering</title><addtitle>Biotechnol. Bioeng</addtitle><description>The success and validity of gene therapy and DNA vaccination in in vivo experiments and human clinical trials depend on the ability to produce large amounts of plasmid DNA according to defined specifications. A new method is described for the purification of a cystic fibrosis plasmid vector (pCF1‐CFTR) of clinical grade, which includes an ammonium sulfate precipitation followed by hydrophobic interaction chromatography (HIC) using a Sepharose gel derivatized with 1,4‐butanediol‐diglycidylether. The use of HIC took advantage of the more hydrophobic character of single‐stranded nucleic acid impurities as compared with double‐stranded plasmid DNA. RNA, denatured genomic and plasmid DNAs, with large stretches of single strands, and lipopolysaccharides (LPS) that are more hydrophobic than supercoiled plasmid, were retained and separated from nonbinding plasmid DNA in a 14‐cm HIC column. Anion‐exchange HPLC analysis proved that >70% of the loaded plasmid was recovered after HIC. RNA and denatured plasmid in the final plasmid preparation were undetectable by agarose electrophoresis. Other impurities, such as host genomic DNA and LPS, were reduced to residual values with the HIC column (<6 ng/μg pDNA and 0.048 EU/μg pDNA, respectively). The total reduction in LPS load in the combined ammonium acetate precipitation and HIC was 400,000‐fold. Host proteins were not detected in the final preparation by bicinchoninic acid (BCA) assay and sodium dodecylsulfate‐polyacrylamide gel electrophoresis (SDS‐PAGE) with silver staining. Plasmid identity was confirmed by restriction analysis and biological activity by transformation experiments. The process presented constitutes an advance over existing methodologies, is scaleable, and meets quality standards because it does not require the use of additives that usually pose a challenge to validation and raise regulatory concerns. © 2000 John Wiley & Sons, Inc. Biotechnol Bioeng 68: 576–583, 2000.</description><subject>Ammonium compounds</subject><subject>Chromatography - methods</subject><subject>Chromatography, High Pressure Liquid</subject><subject>cystic fibrosis</subject><subject>Cystic Fibrosis Transmembrane Conductance Regulator - genetics</subject><subject>Cystic Fibrosis Transmembrane Conductance Regulator - isolation & purification</subject><subject>DNA</subject><subject>Endotoxins - analysis</subject><subject>Escherichia coli - chemistry</subject><subject>Escherichia coli - genetics</subject><subject>gene therapy</subject><subject>Genetic Therapy - methods</subject><subject>Genetic Vectors - isolation & purification</subject><subject>Humans</subject><subject>Hydrophobic chromatography</subject><subject>hydrophobic interaction chromatography</subject><subject>nucleic acids</subject><subject>plasmid purification</subject><subject>Plasmids - genetics</subject><subject>Precipitation (chemical)</subject><subject>Purification</subject><subject>Quality Control</subject><subject>RNA</subject><issn>0006-3592</issn><issn>1097-0290</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNqFke9r1DAYx4so7jb9F6SvZHvRM0mbpD1F2TqdhemJnsx3D7k0vWb215JW7X9vus4hKFwghCTf5_OEfDzvDUZLjBB5cfwlS7MTjBIeIJKgY4LcYIiesHhFX1HOVqvT7Dw4yzY4fB0u0TJdvyQBfeAt7mseeoupJghpQg68Q2uv3ZbHjD32DjDiCScRXXjNp8HoQkvR67bx28IXvhxtr6Vf6K1prbZ-Vwlb69z_oWTfGr9wc6ca5felMqIb_cHqZueXY27army3rlQ3vbuSt0hZmrYWfbtz2XJ84j0qRGXV07v1yPv67u0mfR9cri-y9PQykFHMwyDnOMnzhKlIIKkIxSoOBSOFjBOakwIJyWKWSMEkyaclCmOJJFU8whIVjnDkPZ-5nWlvBmV7qLWVqqpEo9rBAsfI_QShe4MER1FMSLQ3iDljlBDmgldzULrvs0YV0BldCzMCRjDJBZjkwiQKJlHwRy6wGCg4uQBOLtzKhRAQpGsgML312d0Thm2t8r-4s00X-DYHfupKjf_03dv2f13nA4cOZrS2vfp1jxbmOzAecgpXHy_g7DM536APDh3-Bnzv0G4</recordid><startdate>20000605</startdate><enddate>20000605</enddate><creator>Diogo, M. M.</creator><creator>Queiroz, J. A.</creator><creator>Monteiro, G. A.</creator><creator>Martins, S. A. M.</creator><creator>Ferreira, G. N. M.</creator><creator>Prazeres, D. M. F.</creator><general>John Wiley & Sons, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20000605</creationdate><title>Purification of a cystic fibrosis plasmid vector for gene therapy using hydrophobic interaction chromatography</title><author>Diogo, M. M. ; Queiroz, J. A. ; Monteiro, G. A. ; Martins, S. A. M. ; Ferreira, G. N. M. ; Prazeres, D. M. F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4873-d719dd96e4a0ce251e83a62fc895d2f0ac6869ca6c2d9ca6438c0c5e741c0f873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Ammonium compounds</topic><topic>Chromatography - methods</topic><topic>Chromatography, High Pressure Liquid</topic><topic>cystic fibrosis</topic><topic>Cystic Fibrosis Transmembrane Conductance Regulator - genetics</topic><topic>Cystic Fibrosis Transmembrane Conductance Regulator - isolation & purification</topic><topic>DNA</topic><topic>Endotoxins - analysis</topic><topic>Escherichia coli - chemistry</topic><topic>Escherichia coli - genetics</topic><topic>gene therapy</topic><topic>Genetic Therapy - methods</topic><topic>Genetic Vectors - isolation & purification</topic><topic>Humans</topic><topic>Hydrophobic chromatography</topic><topic>hydrophobic interaction chromatography</topic><topic>nucleic acids</topic><topic>plasmid purification</topic><topic>Plasmids - genetics</topic><topic>Precipitation (chemical)</topic><topic>Purification</topic><topic>Quality Control</topic><topic>RNA</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Diogo, M. M.</creatorcontrib><creatorcontrib>Queiroz, J. A.</creatorcontrib><creatorcontrib>Monteiro, G. A.</creatorcontrib><creatorcontrib>Martins, S. A. M.</creatorcontrib><creatorcontrib>Ferreira, G. N. M.</creatorcontrib><creatorcontrib>Prazeres, D. M. F.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Biotechnology and bioengineering</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Diogo, M. M.</au><au>Queiroz, J. A.</au><au>Monteiro, G. A.</au><au>Martins, S. A. M.</au><au>Ferreira, G. N. M.</au><au>Prazeres, D. M. F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Purification of a cystic fibrosis plasmid vector for gene therapy using hydrophobic interaction chromatography</atitle><jtitle>Biotechnology and bioengineering</jtitle><addtitle>Biotechnol. Bioeng</addtitle><date>2000-06-05</date><risdate>2000</risdate><volume>68</volume><issue>5</issue><spage>576</spage><epage>583</epage><pages>576-583</pages><issn>0006-3592</issn><eissn>1097-0290</eissn><abstract>The success and validity of gene therapy and DNA vaccination in in vivo experiments and human clinical trials depend on the ability to produce large amounts of plasmid DNA according to defined specifications. A new method is described for the purification of a cystic fibrosis plasmid vector (pCF1‐CFTR) of clinical grade, which includes an ammonium sulfate precipitation followed by hydrophobic interaction chromatography (HIC) using a Sepharose gel derivatized with 1,4‐butanediol‐diglycidylether. The use of HIC took advantage of the more hydrophobic character of single‐stranded nucleic acid impurities as compared with double‐stranded plasmid DNA. RNA, denatured genomic and plasmid DNAs, with large stretches of single strands, and lipopolysaccharides (LPS) that are more hydrophobic than supercoiled plasmid, were retained and separated from nonbinding plasmid DNA in a 14‐cm HIC column. Anion‐exchange HPLC analysis proved that >70% of the loaded plasmid was recovered after HIC. RNA and denatured plasmid in the final plasmid preparation were undetectable by agarose electrophoresis. Other impurities, such as host genomic DNA and LPS, were reduced to residual values with the HIC column (<6 ng/μg pDNA and 0.048 EU/μg pDNA, respectively). The total reduction in LPS load in the combined ammonium acetate precipitation and HIC was 400,000‐fold. Host proteins were not detected in the final preparation by bicinchoninic acid (BCA) assay and sodium dodecylsulfate‐polyacrylamide gel electrophoresis (SDS‐PAGE) with silver staining. Plasmid identity was confirmed by restriction analysis and biological activity by transformation experiments. The process presented constitutes an advance over existing methodologies, is scaleable, and meets quality standards because it does not require the use of additives that usually pose a challenge to validation and raise regulatory concerns. © 2000 John Wiley & Sons, Inc. Biotechnol Bioeng 68: 576–583, 2000.</abstract><cop>New York</cop><pub>John Wiley & Sons, Inc</pub><pmid>10797245</pmid><doi>10.1002/(SICI)1097-0290(20000605)68:5<576::AID-BIT13>3.0.CO;2-5</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0006-3592 |
ispartof | Biotechnology and bioengineering, 2000-06, Vol.68 (5), p.576-583 |
issn | 0006-3592 1097-0290 |
language | eng |
recordid | cdi_proquest_miscellaneous_71086625 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Ammonium compounds Chromatography - methods Chromatography, High Pressure Liquid cystic fibrosis Cystic Fibrosis Transmembrane Conductance Regulator - genetics Cystic Fibrosis Transmembrane Conductance Regulator - isolation & purification DNA Endotoxins - analysis Escherichia coli - chemistry Escherichia coli - genetics gene therapy Genetic Therapy - methods Genetic Vectors - isolation & purification Humans Hydrophobic chromatography hydrophobic interaction chromatography nucleic acids plasmid purification Plasmids - genetics Precipitation (chemical) Purification Quality Control RNA |
title | Purification of a cystic fibrosis plasmid vector for gene therapy using hydrophobic interaction chromatography |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T17%3A02%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Purification%20of%20a%20cystic%20fibrosis%20plasmid%20vector%20for%20gene%20therapy%20using%20hydrophobic%20interaction%20chromatography&rft.jtitle=Biotechnology%20and%20bioengineering&rft.au=Diogo,%20M.%20M.&rft.date=2000-06-05&rft.volume=68&rft.issue=5&rft.spage=576&rft.epage=583&rft.pages=576-583&rft.issn=0006-3592&rft.eissn=1097-0290&rft_id=info:doi/10.1002/(SICI)1097-0290(20000605)68:5%3C576::AID-BIT13%3E3.0.CO;2-5&rft_dat=%3Cproquest_cross%3E17665226%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4873-d719dd96e4a0ce251e83a62fc895d2f0ac6869ca6c2d9ca6438c0c5e741c0f873%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17665226&rft_id=info:pmid/10797245&rfr_iscdi=true |